Please assess the completion status of the following clinical trial:

Trial Title: Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Healthy Controls~Inclusion Criteria:~* Male or female, age 19-65, no apparent signs of hepatobiliary diseases~Exclusion Criteria:~* Levels higher than 50, 56, 78 U/L for ALT, AST, and GGT, respectively.~Patient Population~Inclusion Criteria:~* Male or female, age 19-65, visiting the UNMC hepatology clinic for treatment from hepatobiliary diseases~Exclusion Criteria:~* MELD score less than 6

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Healthy Controls (Type: None): Male or female, age 19-65, no apparent signs of hepatobiliary diseases
- Patients with hepatobiliary diseases (Type: None): Male or female, age 19-65, visiting the UNMC hepatology clinic for treatment from hepatobiliary diseases

Based on this trial design, predict the completion outcome and termination type (if applicable).